{"id":"W4293332312","doi":"10.1161/circulationaha.122.061754","title":"Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Relypsa; National Medical Research Council; Respicardia; American Regent; National Heart, Lung, and Blood Institute; Japan Heart Foundation; Vifor Pharma; Daiichi-Sankyo; University of Glasgow; Pfizer; Moderna; Medical Research Council; Verily Life Sciences; British Heart Foundation; Cytokinetics; Ionis Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Sarepta Therapeutics; Japan Agency for Medical Research and Development; Sanofi Pasteur; Universitair Medisch Centrum Groningen; Kowa Company; Celladon Corporation; Defense Acquisition Program Administration; Boston Scientific Corporation; Esperion Therapeutics; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Bayer; Gilead Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; GlaxoSmithKline; Amgen; AstraZeneca; Lundbeckfonden; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Dapagliflozin; Heart failure; Ejection fraction; Hazard ratio; Clinical endpoint; Internal medicine; Tolerability; Randomized controlled trial; Canadian Cardiovascular Society; Cardiology; Confidence interval; Adverse effect; Myocardial infarction; Diabetes mellitus; Angina; Type 2 diabetes","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006680901,0.001091086,0.003658711,0.0003473549,0.0002817226,0.0009969671,0.0006388196,0.001073063,0.003525668],"category_scores_gemma":[0.008823057,0.0003401591,0.006014709,0.0005784616,0.000515879,0.0009923895,0.000899548,0.00168673,0.0003846256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005732966,"about_ca_system_score_gemma":0.0005654602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005269206,"about_ca_topic_score_gemma":0.001264569,"domain_scores_codex":[0.9972042,0.001460128,0.000258945,0.0004238338,0.0004308581,0.0002220396],"domain_scores_gemma":[0.9936256,0.002490791,0.002137667,0.000816096,0.0002971639,0.0006326034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9151327,0.0009319367,0.04536067,0.0007279104,0.01775402,0.00008552593,0.0001035802,0.0011968,0.001684183,0.0001908292,0.001929692,0.01490215],"study_design_scores_gemma":[0.4832982,0.0880646,0.3926704,0.0002559306,0.02640255,0.0003370791,0.00009823802,0.004217289,0.0009747822,0.0009569841,0.00259894,0.0001250499],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898436,0.003395006,0.0006782798,0.0003288446,0.00007746701,0.0005937854,0.003584736,0.0000497427,0.001448436],"genre_scores_gemma":[0.9924881,0.0006671792,0.0005092194,0.0004249586,0.0002439296,0.0007791999,0.004199957,0.00001935991,0.000668117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006680901,"threshold_uncertainty_score":0.03533244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0189463547770563,"score_gpt":0.2487504831597485,"score_spread":0.2298041283826922,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}